The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 6.00
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 1.00 (16.667%)
Open: 6.50
High: 6.50
Low: 6.50
Prev. Close: 6.50
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Envestors closes funding for Cipher Surgical

21 Feb 2013 07:00

RNS Number : 3311Y
Braveheart Investment Group plc
21 February 2013
 



21 February 2013

 

Braveheart Investment Group plc

("Braveheart" or the "Group")

 

Envestors' Members in Monaco invest into Cipher Surgical

 

Braveheart Investment Group plc ('Braveheart', the 'Group' or the 'Company') (BRH), the AIM-listed investment management group, announces that Envestors Limited, its wholly owned subsidiary, has closed funding from private investors in Monaco as part of a £1.2m funding round for Cipher Surgical

 

Cipher Surgical presented at an event hosted by the Monaco Venture Capital Association (MVCA) at which Envestors was invited to participate. Donald Anderson, a resident of Monaco who works with Envestors, invested into Cipher Surgical alongside other Monaco-based private investors.

 

The OpClear product developed by Cipher Surgical is a novel solution to one of the key challenges facing surgeons in laparoscopy (minimally invasive surgery through the abdomen) - how to maintain soil free optics throughout an operation and ensure continuous operative surgical vision.

 

During laparoscopy, the lens of the laparoscope acts as the surgeon's eyes. But it can become covered in fluid, blood, tissue, fat or condensation any of which will impair the surgeon's view as projected on the external screen. To clean the lens the laparoscope needs to be removed from the patient's abdomen causing an unwelcome break in the surgeon's workflow and concentration.

 

The OpClear is a laparoscopic accessory comprising a single use device that fits to a laparoscope and uses fluidics in a novel way to clear the laparoscope lens. It is easy to use and has received endorsement from a number of leading laparoscopic surgeons.

 

Oliver Woolley, Founder Director of Envestors, said: "We have worked with Andrew Newell, CEO of Cipher Surgical, and the team for a couple of years and have watched the progress made by the company in developing this ground-breaking solution. We are most encouraged to see that Cipher Surgical has made good progress with its CE mark application and has agreed terms with a UK distributor. The product was also very well received at Medica in November 2012 and, more recently, at Arab Health." 

Andrew Newell, CEO Cipher Surgical Limited, added: "This additional funding will enable us to obtain our CE mark and launch into the UK. The fundraising ability and responsiveness of the Envestors team has been a great help to us."

 

 

Further information:

 

Braveheart Investment Group plc

Geoffrey Thomson, Chief Executive

gthomson@braveheartgroup.co.uk

Tel: 01738 587555

 

Merchant Securities Limited (Nominated Adviser and Broker to Braveheart)

Lindsay Mair

Catherine Miles

Tel: 020 7628 2200

 

 

Envestors Limited

Oliver Woolley, Managing Director

oliver@envestors.co.uk

Tel: 020 7240 0202

 

Cipher Surgical

Andrew Newell, Managing Director

anewell@ciphersurgical.com

Tel: 020 7801 0087

 

Media enquiries:

Allerton Communications

Peter Curtain

peter.curtain@allertoncomms.co.uk

Tel: 020 3137 2500

 

Notes to Editors

 

Braveheart Investment Group plc

 

Braveheart provides financing and associated advisory services for small and medium sized enterprises (SMEs) as follows: 

 

For the company looking to raise money, we provide:

 

·; Equity capital. This form of financing is typically long term and is usually appropriate for fast growing businesses or early stage companies. We will consider equity financings where our individual investment, or the investment we arrange, would normally be a maximum of £2m although we are happy to participate in larger financings as part of a syndicate;

·; Debt finance. Short to medium term and for companies with cash flow to service the loan. Our unit size for this type of finance is up £1m and we will usually provide junior debt which is unsecured but linked to an equity instrument; and

·; Corporate finance advice on all aspects of raising money, strategic development and corporate governance.

 

The money we invest comes from a variety of sources (see below) and is sometimes linked to particular geographical locations.

 

To the investor, we provide a one stop shop service to those in one of the following groups who are looking for exposure to SME investments:

 

·; High net worth (HNW) individuals looking to build tax efficient Enterprise Investment Scheme (EIS) and Seed EIS portfolios;

·; Family offices and private sector institutions; and

·; The Public sector.

 

Investors can choose between investment types ranging from self-build portfolios, to a full fund management service.

 

www.braveheartgroup.co.uk

 

Envestors Limited

 

Envestors enables investors to source dynamic unquoted companies in need of growth capital. Comprising high net worth private investors, family offices, funds and venture capital sources, its network has helped over 65 companies raise in excess of £25 million, the majority of opportunities attracting taxation benefits under the Enterprise Investment Scheme (EIS).

 

Services to companies include intensive preparation for fundraising, initial due diligence and screening, facilitating corporate fundraisings through in-demand investor presentation events and face-to-face meetings with potential investors, and placing of non-executive talent.

 

Envestors was awarded the "Private Investor Network of the Year" at Investor Allstars in 2009 and again in 2011 and is a wholly-owned subsidiary of Braveheart Investment Group plc.

 

www.envestors.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALLFIRFFIIFIV
Date   Source Headline
29th Apr 20242:07 pmRNSHolding(s) in Company
29th Apr 20241:42 pmRNSBlock admission six monthly return
10th Apr 20247:00 amRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSAcquisition of further interest in Autins Group
4th Mar 202411:48 amRNSInvestment update – Paraytec Limited
4th Mar 20247:00 amRNSCompletion of sale of Phasefocus
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSPortfolio update - Proposed sale of Phasefocus
15th Dec 202311:41 amRNSInvestment update - Paraytec Limited
15th Dec 202310:16 amRNSReplacement: Half-year Report
14th Dec 20237:00 amRNSHalf-year Report
29th Nov 20237:00 amRNSInvestment update - Paraytec Limited
14th Nov 20239:02 amRNSHolding(s) in Company
17th Oct 20237:00 amRNSInvestment update – Paraytec Limited
10th Oct 202311:15 amRNSHolding(s) in Company
8th Sep 20237:00 amRNSInvestment update – Kirkstall Limited
8th Sep 20237:00 amRNSBlock admission six monthly return
21st Aug 20237:00 amRNSFurther investment in Phasefocus Holdings Limited
28th Jul 20232:25 pmRNSInvestment update on Paraytec Limited
28th Jul 202311:54 amRNSResult of AGM
5th Jul 20237:00 amRNSPosting of annual report and notice of AGM
4th Jul 20237:00 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
31st May 20237:00 amRNSInvestment update – Phasefocus Holdings Limited
3rd May 20237:00 amRNSUpdate on investments
24th Apr 202310:49 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSGrant of options
13th Mar 20239:34 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSBlock admission six monthly return
10th Feb 20231:26 pmRNSHolding(s) in Company
30th Jan 20234:37 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSOperational update
22nd Dec 20229:14 amRNSHolding(s) in Company
19th Dec 20229:25 amRNSDirector/PDMR Shareholding
19th Dec 20229:11 amRNSAcquisition of interest in Image Scan Holdings plc
13th Dec 20224:37 pmRNSHolding(s) in Company
15th Nov 20223:09 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirector/PDMR Shareholding
28th Oct 20227:00 amRNSHalf-year Report
21st Oct 202210:33 amRNSHolding(s) in Company
20th Oct 20221:59 pmRNSAcquisition of further interest in Autins
5th Oct 20223:15 pmRNSHolding(s) in Company
5th Oct 202212:28 pmRNSAcquisition of further interest in Aukett Swanke
30th Sep 20225:00 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNSPlacing and subscription to raise £750,000
9th Sep 20227:00 amRNSBlock admission six monthly return
6th Sep 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.